Qingsong Health Announces Board Approval of 115 Q2 Consolidated Financial Report

1. Date reported to or resolved by the board of directors: 115/08/12 2. Audit Committee approval date: 115/08/12 3. Reporting period for financial report or self-compiled annual financial information: Start and end dates (XXX/XX/XX ~ XXX/XX/XX): 115/01/01 ~ 115/06/30 4. Cumulative operating revenue from January 1 to end of current period (in thousands of NTD): 630,374 5. Cumulative operating gross profit (loss) from January 1 to end of current period (in thousands of NTD): 99,352 6. Cumulative operating income (loss) from January 1 to end of current period (in thousands of NTD): 47,579 7. Cumulative pre-tax net profit (loss) from January 1 to end of current period (in thousands of NTD): 202,227 8. Cumulative net profit (loss) for the period from January 1 to end of current period (in thousands of NTD): 185,751 9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to end of current period (in thousands of NTD): 177,428 10. Cumulative basic earnings per share (loss) from January 1 to end of current period (in NTD): 2.68 11. Total assets at the end of the period (in thousands of NTD): 2,795,166 12. Total liabilities at the end of the period (in thousands of NTD): 1,465,055 13. Equity attributable to owners of the parent company at the end of the period (in thousands of NTD): 1,296,946 14. Other matters to be disclosed: None